Associations Between Antibiotic Use and Outcomes in Patients Hospitalized With Community-Acquired Pneumonia and Positive Respiratory Viral Assays
Clinical Infectious Diseases · 2026
DOI: 10.1093/cid/ciaf687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Brett Biebelberg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Community-Acquired Infections, Anti-Bacterial Agents, Pneumonia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AHRQ HHS, NCEZID CDC HHS, Harvard Pilgrim Health Care Institute.
Abstract (Originalsprache)
Background
Newly released community-acquired pneumonia (CAP) guidelines include a conditional recommendation to treat all hospitalized patients with positive respiratory virus assays with antibacterials. We assessed the frequency, duration, and outcomes of antibacterial prescribing in this population.
Methods
We retrospectively identified all hospitalized patients with possible CAP and a positive respiratory virus test at 5 hospitals, June 2015–December 2024. We used detailed clinical data to propensity-weight patients treated with 0–2 versus 5–7 days of antibacterials and compared outcomes overall and for different viruses.
Results
Among 6779 patients with possible CAP and a respiratory virus, 3269 were treated with 0–2 days and 1560 with 5–7 days of antibacterials. After propensity-weighting 2614 patients (1720 treated 0–2 days, 894 treated 5–7 days), there were no significant differences in hospital length of stay (11.7 days vs 11.1 days; OR 1.05, 95% CI .97–1.15), ICU admission after 48 hours (28.3% vs 28.2%; OR 1.01, 95% CI .86–1.18), in-hospital mortality (9.5% vs 9.8%; OR 0.97, 95% CI .74–1.27), or 30-day hospital-free days (16.9 days vs 17.0 days; OR 0.99, 95% CI .95–1.03). Results were consistent when restricted to non-SARS-CoV-2 viruses and to influenza alone, when comparing 0 versus 5–7 days of antibacterials, and when restricting to patients with ICD-10 codes for pneumonia present on admission.
Conclusions
Antibacterial use for patients with possible CAP and respiratory viruses is highly variable but outcomes are similar with 0–2 versus 5–7 days of antibacterials. This suggests antibiotics are not beneficial in most CAP patients who test positive for respiratory viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
- Department of Medical Microbiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Brett Biebelberg, Tom Chen, Cara McKenna, Sanjat Kanjilal, Claire Shappell, Chanu Rhee, Michael Klompas
Förderung
- AHRQ HHS
- NCEZID CDC HHS
- Harvard Pilgrim Health Care Institute
- US Centers for Disease Control and Prevention
Zitieren
APA
Biebelberg, B., Chen, T., McKenna, C., Kanjilal, S., Shappell, C., Rhee, C., & Klompas, M. (2026). Associations Between Antibiotic Use and Outcomes in Patients Hospitalized With Community-Acquired Pneumonia and Positive Respiratory Viral Assays. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf687
Vancouver
Biebelberg B, Chen T, McKenna C, Kanjilal S, Shappell C, Rhee C, et al. Associations Between Antibiotic Use and Outcomes in Patients Hospitalized With Community-Acquired Pneumonia and Positive Respiratory Viral Assays. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciaf687
BibTeX
@article{Biebelberg2026,
author = {Biebelberg, Brett and Chen, Tom and McKenna, Cara and Kanjilal, Sanjat and Shappell, Claire and Rhee, Chanu and Klompas, Michael},
title = {Associations Between Antibiotic Use and Outcomes in Patients Hospitalized With Community-Acquired Pneumonia and Positive Respiratory Viral Assays},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciaf687}
}
EUVIMED